MK

Manjula Krishnappa

Active Director Director DIN 07678465
DIN 07678465 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value •••• Premium profile

About Manjula Krishnappa

Data last updated:

Manjula Krishnappa is a Director at Overseas Pharma Private Limited (since 2017). The company operates in Pharma. Overseas Pharma Private Limited reported revenue of ₹25.60 Cr (FY 2025).

DIN 07678465
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2017
Oldest Company Age 67 yrs
Largest company Overseas Pharma Private Limited · ₹25.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Overseas Pharma Private Limited U24119KA1959PTC001361
Director16 Jan 20171959₹25.60 Cr (FY 2025)Active

Board colleagues of Manjula Krishnappa

Directorship timeline

Open interactive timeline →
Overseas Pharma Private Limited
Premium access

Shareholding and investment profile for Manjula Krishnappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjula Krishnappa

Manjula Krishnappa currently holds 1 directorship: Overseas Pharma Private Limited (Director, since 16 Jan 2017, revenue ₹25.60 Cr (FY 2025)).

Manjula Krishnappa was first appointed on 16 Jan 2017 as Director at Overseas Pharma Private Limited.

The current boards of Manjula Krishnappa's companies include Nerendranath Venkatachala (Overseas Pharma Private Limited), Thimmaiah Thimme Gowda (Overseas Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available